Innervace (Series A)
Funding Details
Awarder
Inbox
Date Award
September 8, 2022
Vertical
Regenerative Therapy
Funding Amount
$40,000,000
Company Info
Founders
Nader Halim, Ph.D.
Market
Healthcare
Location
New York, NY, USA
Coinvestors
BioAdvance, Deerfield Management Company, L.P., IP Group, Penn Medicine, WARF Ventures
Company Description

Innvervace develops regenerative therapy solutions for neurodegenerative disorders.